IP Library Granted Patent US 9,650,675
Granted Patent B2
US 9,650,675 · App. 14/972,566 · Granted May 16, 2017

Restriction endonucleases and their uses

Inventors: Renata Rimseliene (Vilnius, LT); Remigijus Skirgalia (Vilnius, LT); Arvydas Lubys (Vilnius, LT)
Assignee: Thermo Fisher Scientific Baltics UAB
C12Q1/6876C12N9/22C12Q1/683C12Q1/6883C12Q2600/154C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,675
App. No.
14/972,566
Granted
May 16, 2017
Kind
B2
Abstract

A restriction endonuclease with a recognition sequence 5′-TCGA-3′. The restriction endonuclease is sensitive to the presence of a modified cytosine residue in the recognition sequence. Methods and kits using the restriction endonuclease with a recognition sequence 5′-TCGA-3′ are also disclosed.

Claims (16)

1. A method for determining the level of methylation in eukaryotic double stranded DNA, the method comprising

contacting a first sample of the eukaryotic double stranded DNA with a restriction endonuclease comprising SEQ ID NO. 4 or a sequence at least 70% identical to SEQ ID NO. 4, having a recognition sequence 5′-TCGA-3′ where a modified cytosine residue in the recognition sequence impairs cleavage,

digesting the DNA comprising the recognition sequence 5′-TCGA-3′ in which the cytosine residue is unmodified; and

determining the amount of undigested DNA or digested DNA.

2. The method of claim 1 further comprising

contacting a second sample of the double stranded DNA with a second restriction endonuclease; and

determining the amount of DNA digestion,

where the second restriction endonuclease has a recognition sequence 5′-TCGA-3′ and is not impaired by modification of the cytosine residue.

3. The method of claim 1 wherein the eukaryotic double stranded DNA is genomic DNA.

4. The method of claim 1 wherein the amount of undigested DNA is determined using qPCR.

5. The method of claim 2 where the second restriction endonuclease is TaqI.

6. The method of claim 1 wherein the impaired ability to cleave the recognition sequence means that under conditions at which the restriction endonuclease is most active, optimal reaction conditions, the presence of the modified cytosine residue in the recognition sequence reduces the endonuclease's ability to cleave the sequence by more than 80%.

7. The method of claim 6 wherein the presence of the modified cytosine residue in the recognition sequence reduces the endonuclease's ability to cleave the sequence by more than 90%.

8. The method of claim 6 wherein the percent of DNA cleavage is determined by qPCR analysis.

9. The method of claim 1 wherein the modified cytosine residue is a methylated cytosine.

10. The method of claim 9 wherein the methylated cytosine is selected from the group consisting of 5-methylcytosine, 5-hydroxymethylcytosine, and glycosylated 5-hydroxymethylcytosine.

Assignments (2)
CHANGE OF NAME Recorded Dec 22, 2015
From: FERMENTAS UAB
To: THERMO FISHER SCIENTIFIC BALTICS UAB
Reel/Frame 037371/0027 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2015
From: RIMSELIENE, RENATA; SKIRGAILA, REMIGIJUS; LUBYS, ARVYDAS
To: FERMENTAS UAB
Reel/Frame 037324/0155 →
Priority Claims (1)
GB 1212047.3 · Jul 5, 2012 · national
Continuity (2)
Division 13932365 · Jul 1, 2013
Related Publication 20160194706A1 · Jul 7, 2016